Acrivon Therapeutics, Inc. (ACRV): 10-Q filed Aug 12, 2026

Form type

10-Q

Filing date

Aug 12, 2026

Accession number

0001193125-26-346819

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)